These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9017764)

  • 1. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prevention of insulin-dependent diabetes mellitus].
    Loureiro MM; Duarte R; Boavida JM; Lisboa PE
    Acta Med Port; 1996; 9(10-12):353-60. PubMed ID: 9254534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is insulin-dependent diabetes mellitus a preventable disease?
    Maclaren NK; Riley WJ; Winter WE; Silverstein JH
    Clin Invest Med; 1987 Sep; 10(5):444-9. PubMed ID: 3315366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune intervention for type 1 diabetes mellitus.
    Skyler JS
    Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current indications and limits of pancreatic islet transplantation in diabetic nephropathy.
    Masetti M; Inverardi L; Ranuncoli A; Iaria G; Lupo F; Vizzardelli C; Kenyon NS; Alejandro R; Ricordi C
    J Nephrol; 1997; 10(5):245-52. PubMed ID: 9364315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
    Morrison EY; Ragoobirsingh D; Peter SA
    Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetes intervention trials 2007: where are we and where are we going?
    Haller MJ; Gottlieb PA; Schatz DA
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):283-7. PubMed ID: 17940453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type 1a diabetes mellitus*.
    Wilson DM; Buckingham B
    Pediatr Diabetes; 2001 Mar; 2(1):17-24. PubMed ID: 15016206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus.
    Singh B; Prange S; Jevnikar AM
    Semin Immunol; 1998 Feb; 10(1):79-86. PubMed ID: 9529658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
    Heurtier AH; Boitard C
    Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell behaviour during the prediabetic stage. Part II. Non-insulin-dependent and insulin-dependent diabetes mellitus.
    Homo-Delarche F
    Diabetes Metab; 1997 Dec; 23(6):473-505. PubMed ID: 9496555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation for the prevention of SPIDDM and LADA.
    Pozzilli P; Guglielmi C
    Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and the prevention of insulin-dependent diabetes mellitus.
    Coutant R; Carel JC; Timsit J; Boitard C; Bougnères P
    Diabetes Metab; 1997 Sep; 23 Suppl 3():25-8. PubMed ID: 9342539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
    Boettler T; von Herrath M
    Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.